Clinical Trial Update: A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors. [Phase 1]

View source ↗

Summary

Abbott terminated a Phase 1 pharmacokinetic study of Linifanib (ABT-869) in male patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Linifanib (linifanib)

Snippet

Sponsor: Abbott | Conditions: Advanced Solid Tumors | Phase 1 | Status: TERMINATED